GSK Tuberculosis Screening Data
Ballell, L., Bates, R. H., Young, R. J., Alvarez-Gomez, D., Alvarez-Ruiz, E., Barroso, V., Blanco, D., Crespo, B., Escribano, J., Gonzalez, R., Lozano, S., Huss, S., Santos-Villarejo, A., Martin-Plaza, J. J., Mendoza, A., Rebollo-Lopez, M. J., Remuinan-Blanco, M., Lavandera, J. L., Perez-Herran, E., Gamo-Benito, F. J., Garcia-Bustos, J. F., Barros, D., Castro, J. P. and Cammack, N
As a result of a 2-million-compound anti-mycobacterial phenotypic screening campaign against Mycobacterium Bovis BCG with hit confirmation in M. Tuberculosis H37Rv, 776 hits against BCG including 177 non-cytotoxic H37Rv potent hits were identified and made available.